BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9545306)

  • 1. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide.
    Hirako Y; Usukura J; Uematsu J; Hashimoto T; Kitajima Y; Owaribe K
    J Biol Chem; 1998 Apr; 273(16):9711-7. PubMed ID: 9545306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation.
    Hirako Y; Usukura J; Nishizawa Y; Owaribe K
    J Biol Chem; 1996 Jun; 271(23):13739-45. PubMed ID: 8662839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular cleavage of bullous pemphigoid antigen 180/type XVII collagen and its involvement in hemidesmosomal disassembly.
    Hirako Y; Yoshino K; Zillikens D; Owaribe K
    J Biochem; 2003 Feb; 133(2):197-206. PubMed ID: 12761182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome.
    Nishizawa Y; Uematsu J; Owaribe K
    J Biochem; 1993 Apr; 113(4):493-501. PubMed ID: 8514739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180.
    Giudice GJ; Emery DJ; Diaz LA
    J Invest Dermatol; 1992 Sep; 99(3):243-50. PubMed ID: 1324962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.
    Hopkinson SB; Riddelle KS; Jones JC
    J Invest Dermatol; 1992 Sep; 99(3):264-70. PubMed ID: 1512461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
    Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
    J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BP180 (type XVII collagen) and its role in cutaneous biology and disease.
    Van den Bergh F; Giudice GJ
    Adv Dermatol; 2003; 19():37-71. PubMed ID: 14626817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of BP180 (type XVII collagen) and alpha6 integrin is necessary for stabilization of hemidesmosome structure.
    Hopkinson SB; Findlay K; deHart GW; Jones JC
    J Invest Dermatol; 1998 Dec; 111(6):1015-22. PubMed ID: 9856810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hemidesmosomal transmembrane collagenous molecule, the 180-kDa bullous pemphigoid antigen (BPA II), is phosphorylated with 12-O-tetradecanoylphorbol-13-acetate in a human squamous cell carcinoma cell line (DJM-1).
    Kitajima Y; Owada MK; Fujisawa Y; Seishima M; Yaoita H; Hirako Y; Owaribe K
    Epithelial Cell Biol; 1995; 4(2):70-5. PubMed ID: 8688920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
    Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
    Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin.
    Hopkinson SB; Baker SE; Jones JC
    J Cell Biol; 1995 Jul; 130(1):117-25. PubMed ID: 7790367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester- and calcium-induced reorganization of 180-kDa bullous pemphigoid antigen on the ventral surface of cultured human keratinocytes as studied by immunofluorescence and immunoelectron microscopy.
    Kitajima Y; Owaribe K; Nishizawa Y; Jokura Y; Yaoita H
    Exp Cell Res; 1992 Nov; 203(1):17-24. PubMed ID: 1426040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex.
    Powell AM; Sakuma-Oyama Y; Oyama N; Black MM
    Clin Exp Dermatol; 2005 Nov; 30(6):682-7. PubMed ID: 16197389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.